Pharmacokinetic Interaction Between Diltiazem and ACT-541468 in Healthy Subjects
Completed
Actelion
Phase 1
The main objective of this study is to investigate whether repeated administration of a
cardiac medication (diltiazem) can affect the pharmacokinetics (i.e., amount and time of
presence in the blood) of ACT-541468
Pharmacokinetic Interaction Between Diltiazem and ACT-541468 in Healthy Subjects
Completed
Idorsia Pharmaceuticals Ltd.
Phase 1
The main objective of this study is to investigate whether repeated administration of a
cardiac medication (diltiazem) can affect the pharmacokinetics (i.e., amount and time of
presence in the blood) of ACT-541468
A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of ACT-541468 in Healthy Young Adults and Elderly Subjects
Completed
Actelion
Phase 1
The purpose of this study is to evaluate the tolerability, safety, pharmacokinetics (PK, or
amount of drug over time in the body) and pharmacodynamics (PD, or effects on the body) of
ACT-541468 following multiple ascending doses in healthy adults and following single
ascending doses in healthy elderly subjects when administered in the morning. The safety, PK
and PD of ACT-541468 will also be assessed after repeated evening administration of a
selected dose in both healthy adults and elderly.
A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of ACT-541468 in Healthy Young Adults and Elderly Subjects
Completed
Idorsia Pharmaceuticals Ltd.
Phase 1
The purpose of this study is to evaluate the tolerability, safety, pharmacokinetics (PK, or
amount of drug over time in the body) and pharmacodynamics (PD, or effects on the body) of
ACT-541468 following multiple ascending doses in healthy adults and following single
ascending doses in healthy elderly subjects when administered in the morning. The safety, PK
and PD of ACT-541468 will also be assessed after repeated evening administration of a
selected dose in both healthy adults and elderly.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
